KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Work In Process (2016 - 2025)

Hologic's Work In Process history spans 15 years, with the latest figure at $62.9 million for Q4 2025.

  • For Q4 2025, Work In Process rose 3.8% year-over-year to $62.9 million; the TTM value through Dec 2025 reached $62.9 million, up 3.8%, while the annual FY2025 figure was $68.4 million, 10.32% up from the prior year.
  • Work In Process for Q4 2025 was $62.9 million at Hologic, down from $68.4 million in the prior quarter.
  • Across five years, Work In Process topped out at $70.7 million in Q4 2022 and bottomed at $53.0 million in Q3 2021.
  • The 5-year median for Work In Process is $61.3 million (2024), against an average of $61.7 million.
  • The largest annual shift saw Work In Process grew 29.49% in 2022 before it fell 14.85% in 2023.
  • A 5-year view of Work In Process shows it stood at $54.6 million in 2021, then rose by 29.49% to $70.7 million in 2022, then decreased by 14.85% to $60.2 million in 2023, then rose by 0.66% to $60.6 million in 2024, then rose by 3.8% to $62.9 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Work In Process are $62.9 million (Q4 2025), $68.4 million (Q3 2025), and $64.5 million (Q2 2025).